When developing countries band together, lifesaving drugs become cheaper and easier to buy − with trade-offs

Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can increase access to vital treatments worldwide.

Nahim Bin Zahur, Assistant Professor of Economics, Queen's University, Ontario • conversation
June 17, 2025 • ~10 min

Cutting HIV aid means undercutting US foreign and economic interests − Nigeria shows the human costs

Withdrawing or reducing aid has immediate and often fatal effects − not only for the countries receiving aid but for people around the globe.

Kathryn Rhine, Associate Professor of General Internal Medicine, University of Colorado Anschutz Medical Campus • conversation
May 19, 2025 • ~12 min

Grassroots AIDS activists fought for and won affordable HIV treatments around the world – but PEPFAR didn't change governments and pharma

The US PEPFAR initiative has brought HIV medication to millions of people globally. Behind this progress are the activists that pressured politicians and companies to put patients over patents.

Dan Royles, Associate Professor of History, Florida International University • conversation
Jan. 24, 2023 • ~10 min

10 reasons why Anthony Fauci was ready to be the face of the US pandemic response

2020 was a big year for Fauci – but he's been on the national stage for decades. Here's more about his work before COVID-19 and why he was perfectly poised to help the US respond to the pandemic.

Barbara Gastel, Professor of Veterinary Integrative Biosciences and of Humanities in Medicine, Texas A&M University • conversation
Dec. 17, 2020 • ~10 min

/

1